Chemicals

Global Chlorantraniliprole Market Research Report 2021 - Impact of COVID-19 on the Market

SKU ID :Maia-18979277 | Published Date: 24-Aug-2021 | No. of pages: 111

Description

Chlorantraniliprole (Rynaxpyr) is an insecticide of the ryanoid class.
The Chlorantraniliprole market revenue was xx Million USD in 2016, grew to xx Million USD in 2021, and will reach xx Million USD in 2026, with a CAGR of xx during 2021-2026.

Considering the influence of COVID-19 on the global Chlorantraniliprole market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions.

This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery.

Under COVID-19 Outbreak, how the Chlorantraniliprole Industry will develop is also analyzed in detail in Chapter 1.8 of this report.

Major Players in Chlorantraniliprole market are:
DuPont
Bayer CropScience AG
Beijing Yoloo Pesticide
Jiangsu Agrochem Laboratory
Shenyang Sciencreat Chemicals
FMC Corporation
Dow AgroSciences LLCUSA
Zhejiang Welldone Chemicals
Hebei Veyong Bio-Chemical
Nihon Nohyaku

Most important types of Chlorantraniliprole products covered in this report are:
Suspension Concentrate (SC)
Water Dispersible Granules (WG)
Wettable Powder (WP)

Most widely used downstream fields of Chlorantraniliprole market covered in this report are:
Rice
Soy
Fruits and Vegetables
Corn
Others

Major Region

s or countries covered in this report:
North America
Europe
China
Japan
Middle East and Africa
South America
India
South Korea
Southeast Asia
Others

In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations.

In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out.

In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.